Hypothyroidism
Summary
Hypothyroidism is a clinical syndrome resulting from deficiency of thyroid hormones (T3 and T4). The most common cause in iodine-sufficient areas is autoimmune thyroiditis (Hashimoto's disease). Other causes include post-treatment (radioiodine, surgery), medications (amiodarone, lithium), and central causes (pituitary or hypothalamic disease). Patients present with fatigue, weight gain, cold intolerance, constipation, and dry skin. Diagnosis is made biochemically with elevated TSH and low free T4. Treatment is lifelong levothyroxine replacement, titrated to normalise TSH. Special considerations apply to the elderly, patients with cardiovascular disease, and pregnant women.
Key Facts
- Definition: Clinical syndrome due to thyroid hormone deficiency
- Incidence: Prevalence 2-5%; subclinical 4-10%; more common in women and elderly
- Demographics: F:M 5-8:1; increases with age
- Pathognomonic: Elevated TSH + low fT4 + compatible symptoms
- Gold Standard Investigation: Serum TSH, free T4
- First-line Treatment: Levothyroxine (T4) replacement
- Prognosis: Excellent with treatment; lifelong therapy required
Clinical Pearls
Cardiac Pearl: In elderly patients or those with cardiac disease, start levothyroxine at LOW doses (25-50mcg) to avoid precipitating angina or arrhythmias.
TSH Timing Pearl: Check TSH 6-8 weeks after dose changes - it takes this long for TSH to stabilise. Take levothyroxine fasting before blood test.
Subclinical Pearl: Treat subclinical hypothyroidism if TSH greater than 10, symptomatic, or pregnant/planning pregnancy. Watch and wait if TSH less than 10 and asymptomatic.
Drug Pearl: Many drugs affect thyroid function or levothyroxine absorption: amiodarone, lithium, iron, calcium, PPI.
Pregnancy Pearl: Thyroid requirements increase by 25-50% in pregnancy. Adjust levothyroxine early and monitor closely.
Why This Matters Clinically
Hypothyroidism is extremely common and easily treated, but often missed. Symptoms are non-specific and attributed to aging or depression. A high index of suspicion and simple blood tests enable diagnosis and transformative treatment.
Prevalence
| Population | Prevalence |
|---|---|
| General population (overt) | 1-2% |
| Subclinical hypothyroidism | 4-10% |
| Women over 60 | 6-10% |
| Post-radioiodine/surgery | 20-80% |
Demographics
- Sex: Female predominance 5-8:1
- Age: Increases with age; common in elderly
- Geography: Varies with iodine status (less common in iodine-sufficient areas due to less goitre, more autoimmune)
Risk Factors
| Factor | Association |
|---|---|
| Female sex | 5-8x increased risk |
| Age over 60 | Increased prevalence |
| Family history autoimmune thyroid | Increased |
| Personal history autoimmune disease | Type 1 DM, coeliac, vitiligo, RA |
| Previous thyroid treatment | Surgery, radioiodine |
| Medications | Amiodarone, lithium, interferon, checkpoint inhibitors |
| Neck radiation | Increased |
| Iodine excess or deficiency | Risk factor |
Mechanism Overview
Primary Hypothyroidism (95%)
The thyroid gland itself fails to produce adequate thyroid hormone.
Causes:
-
Hashimoto's Thyroiditis (most common in iodine-sufficient areas)
- Autoimmune destruction of thyroid
- Anti-TPO antibodies in 90%+
- Lymphocytic infiltration and fibrosis
- Gradual gland failure
-
Post-treatment
- Radioiodine for Graves' disease or thyroid cancer
- Thyroidectomy
- External beam radiation to neck
-
Drug-induced
- Amiodarone (both hypo and hyperthyroidism)
- Lithium (blocks hormone release)
- Tyrosine kinase inhibitors
- Checkpoint inhibitors (immune-related)
- Interferon-α
-
Iodine deficiency
- Still the most common cause worldwide
- Endemic goitre
-
Transient thyroiditis
- Postpartum thyroiditis
- Subacute (de Quervain's) thyroiditis
- Silent thyroiditis
Secondary/Central Hypothyroidism (less than 5%)
- Pituitary disease (tumour, surgery, radiation, Sheehan's)
- Hypothalamic disease
- Characterised by LOW/normal TSH with LOW fT4
Thyroid Hormone Physiology
Hypothalamus → TRH
↓
Anterior Pituitary → TSH
↓
Thyroid Gland → T4 (90%) and T3 (10%)
↓
Peripheral conversion T4 → T3 (active hormone)
↓
Negative feedback on hypothalamus and pituitary
In primary hypothyroidism:
- Low T4/T3 → loss of negative feedback → TSH rises
Symptoms
| System | Symptoms |
|---|---|
| General | Fatigue, lethargy, weight gain, cold intolerance |
| Skin | Dry skin, hair loss, brittle nails, periorbital oedema |
| GI | Constipation, decreased appetite |
| Cardiovascular | Bradycardia, dyspnoea |
| Neurological | Poor concentration, depression, slow mentation |
| Musculoskeletal | Myalgia, muscle weakness, cramps |
| Reproductive | Menorrhagia, infertility, decreased libido |
Signs
| Sign | Description |
|---|---|
| Bradycardia | HR less than 60 bpm |
| Dry, cool skin | Reduced sweating |
| Non-pitting oedema | Myxoedema (hands, face) |
| Periorbital puffiness | Characteristic |
| Goitre | May be present (Hashimoto's) or absent |
| Slow relaxation of reflexes | Delayed Achilles reflex relaxation |
| Carpal tunnel syndrome | Common association |
| Hoarse voice | Myxoedematous infiltration of vocal cords |
| Macroglossia | Tongue enlargement |
Subclinical Hypothyroidism
Red Flags - Myxoedema Coma
[!CAUTION]
- Altered consciousness/coma
- Hypothermia (less than 35°C)
- Bradycardia, hypotension
- Hypoventilation
- Hyponatraemia
- Precipitated by infection, cold, sedatives, surgery
General Inspection
- Appearance: puffy face, periorbital oedema
- Voice: hoarse, slow speech
- Affect: flat, slow mentation
- Weight: often increased
- Hair: thin, coarse, loss of lateral eyebrows
Hands
- Dry, cool skin
- Carpal tunnel syndrome signs
- Slow pulse
Neck
- Goitre (may be diffuse in Hashimoto's or absent)
- Thyroidectomy scar
Cardiovascular
- Bradycardia
- Hypotension
- Pericardial effusion (rare, severe cases)
Neurological
- Delayed relaxation of deep tendon reflexes
- Proximal myopathy
- Cerebellar signs (rare)
Skin
- Dry, rough, cool
- Yellow tinge (carotenaemia)
- Non-pitting oedema (myxoedema)
Diagnostic Tests
| Test | Primary Hypothyroidism | Central Hypothyroidism |
|---|---|---|
| TSH | ELEVATED | LOW or normal (inappropriately) |
| Free T4 | LOW | LOW |
| Free T3 | Low or normal | Low or normal |
Initial Investigation
- TSH: First-line screening test
- Free T4: Confirms if TSH abnormal
Additional Tests
| Test | Purpose |
|---|---|
| Anti-TPO antibodies | Confirms autoimmune cause (Hashimoto's) - positive in 90%+ |
| Anti-thyroglobulin antibodies | Additional autoimmune marker |
| Lipid profile | Elevated LDL common |
| FBC | May show anaemia (often macrocytic) |
| U&E | Hyponatraemia in severe cases |
| CK | May be elevated (myopathy) |
| Prolactin | May be elevated (TRH stimulates prolactin) |
Subclinical vs Overt
| Classification | TSH | fT4 |
|---|---|---|
| Overt hypothyroidism | Elevated | Low |
| Subclinical hypothyroidism | Elevated (4.5-10) | Normal |
| Euthyroid | Normal | Normal |
When to Image
- Suspicion of central cause: MRI pituitary
- Goitre with concerning features: Thyroid ultrasound
Management Algorithm
HYPOTHYROIDISM SUSPECTED
↓
┌─────────────────────────────────────────────┐
│ CHECK TSH │
│ (If abnormal, check fT4, consider TPO) │
└─────────────────────────────────────────────┘
↓
┌─────────────────────────────────────────────┐
│ CONFIRM DIAGNOSIS │
│ - TSH elevated + fT4 low = overt │
│ - TSH elevated + fT4 normal = subclinical │
└─────────────────────────────────────────────┘
↓
┌────────────────────────────────────────────────────────────┐
│ TREATMENT DECISION │
├───────────────────┬───────────────────┬────────────────────┤
│ OVERT │ SUBCLINICAL │ SUBCLINICAL │
│ │ TSH greater than │ TSH 4.5-10 │
│ │ 10 │ │
│ TREAT ALL │ TREAT │ Consider treating │
│ │ │ if symptoms, │
│ │ │ pregnant, planning │
│ │ │ pregnancy, young │
└───────────────────┴───────────────────┴────────────────────┘
↓
┌─────────────────────────────────────────────┐
│ LEVOTHYROXINE (T4) │
│ Starting dose depends on patient: │
│ - Young/healthy: 50-100mcg OD │
│ - Elderly/cardiac: 25-50mcg OD │
│ - Titrate by 25mcg every 6-8 weeks │
└─────────────────────────────────────────────┘
↓
┌─────────────────────────────────────────────┐
│ MONITORING │
│ - TSH at 6-8 weeks after dose change │
│ - Once stable, annual TSH │
│ - Target TSH usually 0.5-2.5 │
└─────────────────────────────────────────────┘
Levothyroxine Dosing
| Patient | Starting Dose | Titration |
|---|---|---|
| Young, healthy | 50-100mcg OD | Increase by 25-50mcg every 6-8 weeks |
| Elderly (over 60) | 25-50mcg OD | Increase by 12.5-25mcg every 6-8 weeks |
| Cardiac disease | 25mcg OD | Increase by 12.5-25mcg every 6-8 weeks |
| Severe/myxoedema | IV loading (specialist) | ICU management |
Administration
- Take levothyroxine fasting, 30-60 minutes before breakfast
- OR at bedtime (consistent timing is key)
- Avoid taking with calcium, iron, PPI (reduce absorption)
- Coffee can reduce absorption
Target TSH
- General population: 0.5-2.5 mU/L
- Elderly (over 70): Higher TSH may be acceptable (1-5 mU/L)
- Pregnancy: See specific trimester targets
Subclinical Hypothyroidism
Treat if:
- TSH greater than 10 mU/L
- Symptomatic
- Pregnant or planning pregnancy
- Anti-TPO positive (higher progression risk)
- Young patient
Monitor if:
- TSH 4.5-10, asymptomatic
- Elderly
- Repeat TSH in 3-6 months
Special Populations
Pregnancy:
- Higher levothyroxine requirements (+25-50%)
- Tight control essential for fetal neurodevelopment
- Target TSH: less than 2.5 (1st trimester), less than 3.0 (2nd/3rd)
- Increase dose as soon as pregnancy confirmed
Cardiac Disease:
- Start low (12.5-25mcg), go slow
- Risk of precipitating angina or arrhythmia
- Beta-blockers may be needed
Myxoedema Coma:
- Medical emergency
- IV levothyroxine loading
- IV hydrocortisone (adrenal insufficiency may coexist)
- ICU management
| Complication | Mechanism | Management |
|---|---|---|
| Cardiovascular disease | Elevated LDL, diastolic HTN | Treat hypothyroidism + statins |
| Myxoedema coma | Severe decompensation | ICU, IV T4, steroids |
| Infertility/miscarriage | Thyroid essential for reproduction | Treat before conception |
| Goitre | TSH stimulation | Usually resolves with treatment |
| Depression | Direct and indirect effects | Often improves with T4 |
| Carpal tunnel syndrome | Myxoedematous tissue | May resolve with treatment |
Response to Treatment
- Symptoms improve within 2-4 weeks
- Full biochemical and clinical response: 6-12 weeks
- Weight loss typically modest (2-4 kg)
- Lipid profile improves
Long-Term Outlook
- Excellent prognosis with treatment
- Lifelong replacement therapy required
- Annual monitoring usually sufficient once stable
- No increased mortality if well-controlled
Key Guidelines
-
ATA/AACE Guidelines for Hypothyroidism — Garber JR et al. Endocr Pract. 2012;18(6):988-1028. PMID: 23246686
-
NICE CKS: Hypothyroidism — Updated regularly
-
ETA Guidelines for Subclinical Hypothyroidism — Biondi B et al. Eur Thyroid J. 2021
-
ATA Guidelines for Thyroid Disease in Pregnancy — Alexander EK et al. Thyroid. 2017;27(3):315-389. PMID: 28056690
Key Studies
Levothyroxine Bioequivalence
- Generic levothyroxine is bioequivalent
- Maintain same brand if possible for consistency
Subclinical Hypothyroidism and Cardiovascular Risk
- TSH greater than 10 associated with increased CV events
- Lower TSH elevations uncertain benefit from treatment
- PMID: 20231456
What is hypothyroidism?
Your thyroid gland, which sits in your neck, isn't making enough thyroid hormone. This hormone controls your metabolism - how your body uses energy.
What causes it?
The most common cause is an autoimmune condition called Hashimoto's thyroiditis, where your immune system attacks your thyroid. Other causes include previous thyroid treatment or certain medications.
What is the treatment?
You'll take a daily thyroid hormone tablet (levothyroxine) to replace what your body isn't making. It's usually taken first thing in the morning before breakfast.
Will I take it forever?
Usually yes - most causes of hypothyroidism are permanent. The good news is it's a simple, safe, and effective treatment.
How will I be monitored?
Blood tests to check your thyroid levels every 6-8 weeks until stable, then usually once a year.
Important tips
- Take your tablet at the same time each day
- Don't take it with calcium, iron tablets, or antacids (wait 4 hours)
- Tell your doctor if you become pregnant - dose often needs to increase
-
Garber JR et al. Clinical Practice Guidelines for Hypothyroidism in Adults. Endocr Pract. 2012;18(6):988-1028. PMID: 23246686
-
Alexander EK et al. 2017 Guidelines of the ATA for Thyroid Disease in Pregnancy. Thyroid. 2017;27(3):315-389. PMID: 28056690
-
Jonklaas J et al. Guidelines for the Treatment of Hypothyroidism. Thyroid. 2014;24(12):1670-1751. PMID: 25266247
-
Rodondi N et al. Subclinical hypothyroidism and the risk of coronary heart disease and mortality. JAMA. 2010;304(12):1365-1374. PMID: 20858880
-
Biondi B, Cappola AR, Cooper DS. Subclinical Hypothyroidism: A Review. JAMA. 2019;322(2):153-160. PMID: 31287527
-
Pearce SH et al. 2013 ETA Guideline: Management of Subclinical Hypothyroidism. Eur Thyroid J. 2013;2(4):215-228. PMID: 24783053
-
NICE CKS. Hypothyroidism. 2021.
-
Chaker L et al. Hypothyroidism. Lancet. 2017;390(10101):1550-1562. PMID: 28336049
Viva Points
"Hypothyroidism is thyroid hormone deficiency, most commonly due to autoimmune Hashimoto's thyroiditis. Diagnosis: elevated TSH + low fT4. Treat with levothyroxine - start low in elderly/cardiac patients. Monitor TSH 6-8 weeks after dose changes. Target TSH 0.5-2.5. Subclinical hypothyroidism: treat if TSH greater than 10 or symptomatic."
Key Examination Points
- Slow, hoarse voice
- Periorbital puffiness
- Dry, cool skin
- Bradycardia
- Delayed relaxation of deep tendon reflexes
- Goitre (may be absent)
Common Mistakes
- ❌ Starting full replacement dose in elderly/cardiac patients
- ❌ Checking TSH too soon after dose change (need 6-8 weeks)
- ❌ Forgetting to check fT4 when TSH is mildly elevated
- ❌ Not recognising drug-induced causes (amiodarone, lithium)
- ❌ Not increasing dose in pregnancy
Differentials
- Depression
- Anaemia
- Chronic fatigue syndrome
- Heart failure
- Dementia (in elderly)
Last Reviewed: 2026-01-01 | MedVellum Editorial Team